ArticleBone & joint open2026
The rate of total hip arthroplasty after closed reduction of late-detected hip dislocation : 147 hips followed to patient age 70 years.
Article in Bone & joint open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: The outcome of late-detected developmental dysplasia and dislocation of the hip (DDH) deteriorates with the length of follow-up. The aims of this study were to explore the rate of total hip arthroplasty (THA) with follow-up to patient age 60 to 76 years, and to define risk factors for THA. Methods: Inclusion criteria were patient age at diagnosis < three years, closed reduction, and no acetabular procedures. A total of 114 patients (147 hips) met these criteria: 98 females and 16 males with a mean age of 1.4 years (0.4 to 2.7). Residual acetabular dysplasia was defined as centre-edge (CE) angle < 20° at skeletal maturity. Information on THA was obtained from the Norwegian Arthroplasty Register. Results: Overall, 39% of the hips (n = 54) had residual dysplasia at skeletal maturity, with a mean CE angle of 14.9° (7° to 19°). In total, 52 hips (35%) had undergone THA at a mean patient age of 53.2 years (33 to 71). Risk factors for THA were residual acetabular dysplasia and severe degree of avascular necrosis. Kaplan-Meier survival analysis, with THA as the endpoint, showed survival rates of 95% in hips without residual acetabular dysplasia at patient age 50 years and 76% at 70 years. In hips with residual dysplasia, the survival rate was 83% at age 50 years and 41% at 70 years. The estimated mean survival time was significantly lower in hips with residual dysplasia than in hips without dysplasia (62.6 years vs 71.4 years; p < 0.001). Conclusion: The long-term outcome was very good in hips with no residual dysplasia at skeletal maturity. Only 24% of such hips had undergone THA at patient age 70 years. Dysplastic hips showed markedly worse outcomes, with a THA rate of 59% at 70 years. Routine concurrent pelvic osteotomy at the time of reduction in children < three years at diagnosis is hardly indicated.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.